2017

04/27/2017 Q1 2017 revenue: Confirmation of the trend that started in the fourth quarter of 2016

€197.3 million at constant exchange rates, up 7.4%

[more]


04/20/2017 ECIO 2017: Guerbet mobilized for interventional oncology

ECIO 2017 │ Booth No. 9 │ From April 23 to 26 │ Euskalduna Conference Centre │ Bilbao (Spain)

[more]


03/29/2017 2016 annual results: a year that has lived up to expectations

Objective of a sales turnaround after the CMDS acquisition achieved. Slight growth in revenue expected in 2017 at constant exchange rates. EBITDA at constant exchange rates in line with expectations.

[more]


03/13/2017 Gadolinium-based Contrast Agents: update on PRAC recommendations

Villepinte, March 13, 2017 - Guerbet takes note of the recommendations issued by the Pharmacovigilance Risk Assessment Committee (PRAC), on Gadolinium-based Contrast Agents - procedure under Article 31 of Directive 2001/83/EC.

[more]


02/27/2017 ECR 2017: Guerbet will be there!

ECR 2017 | Expo Hall X2 – Booth 21 | from March 1 to 5 | Austria Center Vienna ӏ Vienna (Austria)

[more]


02/16/2017 Explore 90 years of passion on guerbet90.com

As part of the “90 Years of Passion” campaign, Guerbet is launching a website, guerbet90.com, on the birth date of its founder, André Guerbet.

[more]


Displaying results 1 to 7 out of 8
<< First < Previous 1-7 8-8 Next > Last >>